Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Provider’s Clinical Support System - Medication Assisted Treatment Grant
The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT) is accepting applications for fiscal year (FY) 2019 Provider’s Clinical Support System - Medication Assisted Treatment (Short Title:
PCSS-MAT) grant.
The purpose of
this program is to expand the number of Drug Addiction Treatment Act (DATA) 2000 waived providers, increase understanding of the importance of medication-assisted treatment and ultimately increase access to MAT through expanded prescribing of FDA-approved medications for the treatment of opioid use disorders.
Although the current initiative has provided multiple trainings and mentoring support, there still remains a significant need to increase the number of healthcare providers to address the nation’s lack of adequate access to care and treatment for opioid and other substance use disorders.
The PCSS-MAT program will continue to provide up-to-date and evidence-based information to support the training of health professionals and to address the complex issues of addiction.
PCSS-MAT) grant.
The purpose of
this program is to expand the number of Drug Addiction Treatment Act (DATA) 2000 waived providers, increase understanding of the importance of medication-assisted treatment and ultimately increase access to MAT through expanded prescribing of FDA-approved medications for the treatment of opioid use disorders.
Although the current initiative has provided multiple trainings and mentoring support, there still remains a significant need to increase the number of healthcare providers to address the nation’s lack of adequate access to care and treatment for opioid and other substance use disorders.
The PCSS-MAT program will continue to provide up-to-date and evidence-based information to support the training of health professionals and to address the complex issues of addiction.
Agency: Department of Health and Human Services
Office: Substance Abuse and Mental Health Services Adminis
Estimated Funding: $2,000,000
Office: Substance Abuse and Mental Health Services Adminis
Estimated Funding: $2,000,000
Obtain Full Opportunity Text:
.
Additional Information of Eligibility:
Eligibility is limited to the national professional medical organizations authorized by the Drug Addiction Treatment Act of 2000 (DATA) to carry out the training of providers desiring to prescribe and/or dispense FDA-approved schedule III medications for addictive disorders.
These organizations are the American Society of Addiction Medicine (ASAM), the American Academy of Addiction Psychiatry (AAAP), the American Medical Association (AMA), the American Osteopathic Academy of Addiction Medicine (AOAAM), and the American Psychiatric Association (APA).
Any of these entities may apply individually; they may also apply as a consortium comprised of all or several of the eligible organizations.
If a consortium is formed for this purpose, a single organization in the consortium must be the legal applicant, the recipient of the award, and the entity legally responsible for satisfying the grant requirements.
If a consortium submits an application, a written agreement must be included outlining the roles and responsibilities of each participating national professional medical organization.
This agreement must be signed by an authorized official of each member of the consortium and included in Attachment 3 of the application, “Roles and Responsibilities of Participating National Professional Medical Organizations.” There is a serious public health issue involving the abuse, misuse, non-medical use and concomitant morbidity and mortality associated with the increased availability of opioids for the treatment of acute pain, chronic pain, and opioid-related addiction.
While these medications are mainly obtained legally through prescriptions, SAMHSA surveys indicate significant amounts are obtained through theft and other forms of diversion.
In addition, SAMHSA recognizes the difficulty in assessing patients for appropriate opioid prescribing and the limited training that physicians, psychiatrists, and dentists may receive during their formal, specialized training.
Moreover, licensed physicians who have completed their formal training may lack adequate mentoring, continuing medical education, and other resources to evaluate patients and prescribe opioid analgesics appropriately.
To address this public health problem in a timely manner, SAMHSA is limiting eligibility to these five organizations because they have extensive experience providing educational and other support services for addictive disorders to physicians and other substance abuse and healthcare professionals.
As such, SAMHSA believes they are uniquely qualified to meet the requirements outlined in this announcement because they have the experience, infrastructure, and capacity in place to expeditiously begin program activities.
Full Opportunity Web Address:
https://www.samhsa.gov/grants/grant-announcements/ti-19-005
Contact:
Agency Email Description:
FOACSAT@samhsa.hhs.gov
Agency Email:
Date Posted:
2018-12-28
Application Due Date:
Archive Date:
2019-03-28
Follow @topgovtgrant
Social Entrepreneurship
Spotlight
Social Enterprise Piles Textbooks for Change
Textbooks for Change, a London-based social enterprise that has obtained the B Corporation seal for positive social and environmental impact, is seeking investors that would be helping the company expand.
Nonprofit Jobs in Alabama
Fundraising & Development Jobs
Social Services Employment
Substance Abuse Jobs
Program Director Jobs
Social Services Jobs
Learn How to Identify and Avoid Grant Scams
